Heverlee, Belgium

Jan Marie Balzarini


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 140(Granted Patents)


Location History:

  • Egenhoven, BE (1998)
  • Heverlee, BE (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jan Marie Balzarini: Innovator in Antiviral Pharmaceutical Compositions

Introduction

Jan Marie Balzarini is a notable inventor based in Heverlee, Belgium. He has made significant contributions to the field of antiviral pharmaceuticals, particularly in the development of nucleotide analogs. His work has led to the creation of innovative compounds that are essential in treating retroviral infections.

Latest Patents

Balzarini holds two patents that focus on antiretroviral enantiomeric nucleotide analogs. His latest patents include compounds that are useful in antiviral pharmaceutical compositions to treat retroviral infections. One of his inventions involves resolved enantiomers of the formula wherein B is a purine or pyrimidine base or aza and/or deaza analogs. Another significant patent is for N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases. This invention relates to the suppression of the multiplication of viruses, particularly retroviruses, through the application of these new compounds.

Career Highlights

Throughout his career, Balzarini has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences and Rega Stichting. His research has been pivotal in advancing the understanding and treatment of viral infections.

Collaborations

Balzarini has collaborated with notable colleagues, including Antonin Holy and Hana Dvorakova. Their combined expertise has contributed to the success of his research and innovations.

Conclusion

Jan Marie Balzarini's contributions to antiviral pharmaceutical compositions have made a significant impact in the field of medicine. His innovative patents and collaborations highlight his dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…